Systematic review of 99 extremity bone malignancy survival prediction models

Abstract Background Various prediction models have been developed for extremity metastasis and sarcoma. This systematic review aims to evaluate extremity metastasis and sarcoma models using the utility prediction model (UPM) evaluation framework. Methods We followed Preferred Reporting Items for Sys...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng-Yo Lai, Hung-Kuan Yen, Hao-Chen Lin, Olivier Quinten Groot, Wei-Hsin Lin, Hao-Ping Hsu
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:Journal of Orthopaedics and Traumatology
Subjects:
Online Access:https://doi.org/10.1186/s10195-025-00821-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571452764717056
author Cheng-Yo Lai
Hung-Kuan Yen
Hao-Chen Lin
Olivier Quinten Groot
Wei-Hsin Lin
Hao-Ping Hsu
author_facet Cheng-Yo Lai
Hung-Kuan Yen
Hao-Chen Lin
Olivier Quinten Groot
Wei-Hsin Lin
Hao-Ping Hsu
author_sort Cheng-Yo Lai
collection DOAJ
description Abstract Background Various prediction models have been developed for extremity metastasis and sarcoma. This systematic review aims to evaluate extremity metastasis and sarcoma models using the utility prediction model (UPM) evaluation framework. Methods We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and systematically searched PubMed, Embase, and Cochrane to identify articles presenting original prediction models with 1-year survival outcome for extremity metastasis and 5-year survival outcome for sarcoma. Identified models were assessed using the UPM score (0–16), categorized as excellent (12–16), good (7–11), fair (3–6), or poor (0–2). A total of 5 extremity metastasis and 94 sarcoma models met inclusion criteria and were analyzed for design, validation, and performance. Results We assessed 5 models for extremity metastasis and 94 models for sarcoma. Only 4 out of 99 (4%) models achieved excellence, 1 from extremity metastasis and 3 from sarcoma. The majority were rated good (62%; 61/99), followed by fair (31%, 31/99) and poor (3%, 3/99). Conclusions Most predictive models for extremity metastasis and sarcoma fall short of UPM excellence. Suboptimal study design, limited external validation, and the infrequent availability of web-based calculators are main drawbacks. Level of evidence This study is classified as Level 2a evidence according to the Oxford 2011 Levels of Evidence. Trial registration This study was registered in PROSEPRO (CRD42022373391, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=373391 ).
format Article
id doaj-art-776a0410e7da4454a77a74097762dd95
institution Kabale University
issn 1590-9999
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series Journal of Orthopaedics and Traumatology
spelling doaj-art-776a0410e7da4454a77a74097762dd952025-02-02T12:36:34ZengSpringerOpenJournal of Orthopaedics and Traumatology1590-99992025-01-0126111010.1186/s10195-025-00821-6Systematic review of 99 extremity bone malignancy survival prediction modelsCheng-Yo Lai0Hung-Kuan Yen1Hao-Chen Lin2Olivier Quinten Groot3Wei-Hsin Lin4Hao-Ping Hsu5Department of Orthopedic Surgery, National Taiwan University Hospital Hsinchu BranchDepartment of Orthopedic Surgery, National Taiwan University HospitalDepartment of Medical Education, National Taiwan University HospitalDepartment of Orthopaedics, University Medical Center UtrechtDepartment of Orthopedic Surgery, National Taiwan University HospitalDepartment of Medical Imaging, Chi Mei Medical CenterAbstract Background Various prediction models have been developed for extremity metastasis and sarcoma. This systematic review aims to evaluate extremity metastasis and sarcoma models using the utility prediction model (UPM) evaluation framework. Methods We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and systematically searched PubMed, Embase, and Cochrane to identify articles presenting original prediction models with 1-year survival outcome for extremity metastasis and 5-year survival outcome for sarcoma. Identified models were assessed using the UPM score (0–16), categorized as excellent (12–16), good (7–11), fair (3–6), or poor (0–2). A total of 5 extremity metastasis and 94 sarcoma models met inclusion criteria and were analyzed for design, validation, and performance. Results We assessed 5 models for extremity metastasis and 94 models for sarcoma. Only 4 out of 99 (4%) models achieved excellence, 1 from extremity metastasis and 3 from sarcoma. The majority were rated good (62%; 61/99), followed by fair (31%, 31/99) and poor (3%, 3/99). Conclusions Most predictive models for extremity metastasis and sarcoma fall short of UPM excellence. Suboptimal study design, limited external validation, and the infrequent availability of web-based calculators are main drawbacks. Level of evidence This study is classified as Level 2a evidence according to the Oxford 2011 Levels of Evidence. Trial registration This study was registered in PROSEPRO (CRD42022373391, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=373391 ).https://doi.org/10.1186/s10195-025-00821-6Extremity bone malignancyExtremity metastasisSarcomaPrediction modelsSystematic review
spellingShingle Cheng-Yo Lai
Hung-Kuan Yen
Hao-Chen Lin
Olivier Quinten Groot
Wei-Hsin Lin
Hao-Ping Hsu
Systematic review of 99 extremity bone malignancy survival prediction models
Journal of Orthopaedics and Traumatology
Extremity bone malignancy
Extremity metastasis
Sarcoma
Prediction models
Systematic review
title Systematic review of 99 extremity bone malignancy survival prediction models
title_full Systematic review of 99 extremity bone malignancy survival prediction models
title_fullStr Systematic review of 99 extremity bone malignancy survival prediction models
title_full_unstemmed Systematic review of 99 extremity bone malignancy survival prediction models
title_short Systematic review of 99 extremity bone malignancy survival prediction models
title_sort systematic review of 99 extremity bone malignancy survival prediction models
topic Extremity bone malignancy
Extremity metastasis
Sarcoma
Prediction models
Systematic review
url https://doi.org/10.1186/s10195-025-00821-6
work_keys_str_mv AT chengyolai systematicreviewof99extremitybonemalignancysurvivalpredictionmodels
AT hungkuanyen systematicreviewof99extremitybonemalignancysurvivalpredictionmodels
AT haochenlin systematicreviewof99extremitybonemalignancysurvivalpredictionmodels
AT olivierquintengroot systematicreviewof99extremitybonemalignancysurvivalpredictionmodels
AT weihsinlin systematicreviewof99extremitybonemalignancysurvivalpredictionmodels
AT haopinghsu systematicreviewof99extremitybonemalignancysurvivalpredictionmodels